These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells. Jeong Seo E, Jung Kim H, Jae Lee C, Tae Kang H, Seong Hwang E. Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117 [Abstract] [Full Text] [Related]
7. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene. Spitkovsky D, Aengeneyndt F, Braspenning J, von Knebel Doeberitz M. Oncogene; 1996 Sep 05; 13(5):1027-35. PubMed ID: 8806692 [Abstract] [Full Text] [Related]
8. Bovine papillomavirus E2 protein activates a complex growth-inhibitory program in p53-negative HT-3 cervical carcinoma cells that includes repression of cyclin A and cdc25A phosphatase genes and accumulation of hypophosphorylated retinoblastoma protein. Naeger LK, Goodwin EC, Hwang ES, DeFilippis RA, Zhang H, DiMaio D. Cell Growth Differ; 1999 Jun 05; 10(6):413-22. PubMed ID: 10392903 [Abstract] [Full Text] [Related]
9. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53. Sima N, Wang W, Kong D, Deng D, Xu Q, Zhou J, Xu G, Meng L, Lu Y, Wang S, Ma D. Apoptosis; 2008 Feb 05; 13(2):273-81. PubMed ID: 18060502 [Abstract] [Full Text] [Related]
10. Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin-1alpha. Iglesias M, Yen K, Gaiotti D, Hildesheim A, Stoler MH, Woodworth CD. Oncogene; 1998 Sep 10; 17(10):1195-205. PubMed ID: 9771962 [Abstract] [Full Text] [Related]
11. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. Rampias T, Sasaki C, Weinberger P, Psyrri A. J Natl Cancer Inst; 2009 Mar 18; 101(6):412-23. PubMed ID: 19276448 [Abstract] [Full Text] [Related]
12. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells. Ristriani T, Fournane S, Orfanoudakis G, Travé G, Masson M. Oncogene; 2009 Feb 05; 28(5):762-72. PubMed ID: 19015633 [Abstract] [Full Text] [Related]
13. Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells. Rincon-Orozco B, Halec G, Rosenberger S, Muschik D, Nindl I, Bachmann A, Ritter TM, Dondog B, Ly R, Bosch FX, Zawatzky R, Rösl F. Cancer Res; 2009 Nov 15; 69(22):8718-25. PubMed ID: 19887612 [Abstract] [Full Text] [Related]
14. [Human papillomavirus type 16 E6 oncogene and expression of P53, RB and PCNA in human cervical carcinoma]. Bian J, Yu X, Dong J, Zhao W, Zhou Y, Luan Y. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep 15; 11(3):271-3. PubMed ID: 15617346 [Abstract] [Full Text] [Related]
15. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes. Nees M, Geoghegan JM, Munson P, Prabhu V, Liu Y, Androphy E, Woodworth CD. Cancer Res; 2000 Aug 01; 60(15):4289-98. PubMed ID: 10945644 [Abstract] [Full Text] [Related]
16. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer. Fujii T, Saito M, Iwasaki E, Ochiya T, Takei Y, Hayashi S, Ono A, Hirao N, Nakamura M, Kubushiro K, Tsukazaki K, Aoki D. Int J Oncol; 2006 Sep 01; 29(3):541-8. PubMed ID: 16865269 [Abstract] [Full Text] [Related]
17. Study on the carcinogenic mechanism of human papillomavirus typel6 E7 protein in cervical carcinoma. Wang P, Peng Z, Wang H. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Jun 01; 14(2):117-20. PubMed ID: 11503038 [Abstract] [Full Text] [Related]